- £3.99bn
- £3.95bn
- £8.17bn
- 52
- 69
- 87
- 82
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,385 | 3,009 | 1,458 | 5,769 | 8,171 |
Cost of Revenue | |||||
Gross Profit | 2,710 | 1,143 | 534 | 2,433 | 3,334 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5,919 | 3,908 | 2,368 | 5,796 | 7,718 |
Operating Profit | 466 | -899 | -910 | -27 | 453 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 430 | -1,273 | -1,036 | -208 | 432 |
Provision for Income Taxes | |||||
Net Income After Taxes | 349 | -1,079 | -858 | -169 | 324 |
Net Income Before Extraordinary Items | |||||
Net Income | 349 | -1,079 | -858 | -169 | 324 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 349 | -1,079 | -858 | -169 | 324 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.734 | -1.48 | -1.74 | -0.124 | 0.467 |
Dividends per Share |